Veterinary Medicines

Hipraviar Clon/H120 Liofilizat do sporządzania zawiesiny

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain CLON CL/79, Live
Download as PDF

Product identification

Medicine name:
Hipraviar Clon/H120 Liofilizat do sporządzania zawiesiny
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain CLON CL/79, Live
Target species:
  • Chicken (hen)
Route of administration:
  • Nebulisation use
  • Nasal use
  • In drinking water use
  • Ocular use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    1000.00
    50% Embryo Infective Dose
    /
    1.00
    50% Embryo Infective Dose
  • Newcastle disease virus, strain CLON CL/79, Live
    3162280.00
    50% Embryo Infective Dose
    /
    1.00
    50% Embryo Infective Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken (hen)
      • All relevant tissues
        0
        day
  • Nasal use
    • Chicken (hen)
      • All relevant tissues
        0
        day
  • In drinking water use
    • Chicken (hen)
      • All relevant tissues
        0
        day
  • Ocular use
    • Chicken (hen)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1303
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."